{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "single-blind randomised controlled trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "184 patients with stage III or IV ovarian cancer and residual tumor size less than 1 cm"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised (1:1) to receive HIPEC (41.5 \u00b0C, 75 mg/m\u00b2 of cisplatin, 90 minutes) or standard care"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the clinical benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) following primary or interval cytoreductive surgery in women with stage III or IV ovarian cancer."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was progression-free survival, measured from randomisation to disease progression or death."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Randomisation was performed intraoperatively"
      },
      "Blinding": {
        "score": 1,
        "evidence": "participants were blinded to group allocation"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 184 patients"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "An intention-to-treat analysis was conducted."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "HIPEC improved progression-free survival (HR, 0.60; 95% CI, 0.37-0.99; P = .04) and overall survival (HR, 0.53; 95% CI, 0.29-0.96; P = .04)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were more frequent in the HIPEC group, with increased prothrombin time and acute kidney injury being notable."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "NCT01091636"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 18,
    "max_score": 25
  },
  "model": "gpt-4o"
}